Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations
暂无分享，去创建一个
R. Tait | S. Schulman | A. Mumford | B. Boneu | R. Klamroth | M. Depka | A. Tiede | M. von Depka | C. Dempfle | M. Horellou | J. Frieling | J. Conard | J. Lazarchick | C. Shiach | F. Baudo | D. W. Shaffer | L. J. Bonfiglio | Don W. Shaffer